Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ikeda S et al. – It was recently reported that expression of excision repair cross–complementation group 1 (ERCC1), a DNA repair protein, predicts sensitivity to platinum–based chemotherapy drugs. The purpose of the present study was to examine the correlation between prognosis and expression of these proteins using biopsy tissues obtained from 40 patients with advanced inoperable non–small cell lung cancer. It was concluded that determination of the expression of these proteins is useful to predict the effects of platinum–based anticancer drugs.

Today in Lung/Thoracic Oncology...keeping you current

A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Oncogene, 11/25/09

Fhit regulates invasion of lung tumor cells
Oncogene, 11/25/09

Choroidal metastases from lung adenocarcinoma
Clinical and Translational Oncology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address